Floatz logo

Palonosetron

Ovarian Tumors

Zhejiang UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Ovarian Tumors cohort.

Asset / SponsorPhaseRating
Grn-300
Green3Bio, Inc.
Phase 1CC
DROPERIDOL
Zhejiang University
N/AD

Same molecule, other indications

Palonosetron is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
Breast Cancer Patients Treated With T-DXdDormant
BBB
Indicative ·
74 / 100
View asset →
Nausea and VomitingDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →